Triggers of Hospitalization for Venous Thromboembolism
暂无分享,去创建一个
V. Chopra | K. Langa | M. Rogers | D. Levine | S. Flanders | N. Blumberg
[1] W. Baine,et al. The Agency for Healthcare Research and Quality , 2006, Italian Journal of Public Health.
[2] D. Davenport,et al. Association of blood transfusion and venous thromboembolism after colorectal cancer resection. , 2012, Thrombosis research.
[3] L. Smeeth,et al. Acute infections and venous thromboembolism , 2011, Journal of internal medicine.
[4] J. Carson,et al. Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. , 2012, The Cochrane database of systematic reviews.
[5] T. McMahon,et al. Impaired adenosine-5′-triphosphate release from red blood cells promotes their adhesion to endothelial cells: A mechanism of hypoxemia after transfusion* , 2011, Critical care medicine.
[6] Jason D. Wright,et al. Physician characteristics and variability of erythropoiesis-stimulating agent use among Medicare patients with cancer. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[7] A. Turpie,et al. Predictive and associative models to identify hospitalized medical patients at risk for VTE. , 2011, Chest.
[8] Carol Coupland,et al. Development and validation of risk prediction algorithm (QThrombosis) to estimate future risk of venous thromboembolism: prospective cohort study , 2011, BMJ : British Medical Journal.
[9] Ruihua Yin,et al. H1N1 and seasonal influenza vaccine safety in the vaccine safety datalink project. , 2011, American journal of preventive medicine.
[10] M. Mittleman,et al. Recent Advances in Preventive Cardiology and Lifestyle Medicine Physical, Psychological and Chemical Triggers of Acute Cardiovascular Events Preventive Strategies , 2011 .
[11] T. van der Poll,et al. The effect of inflammation on coagulation and vice versa , 2011, Current opinion in infectious diseases.
[12] T. Meade,et al. Recent respiratory infection and risk of venous thromboembolism: case–control study through a general practice database , 2011, International journal of epidemiology.
[13] A. Neugut,et al. Physician characteristics and variability of erythropoiesis-stimulating agent use among Medicare patients with cancer. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[14] J. Hippisley-Cox,et al. Antipsychotic drugs and risk of venous thromboembolism: nested case-control study , 2010, BMJ : British Medical Journal.
[15] Banafsheh Sadeghi,et al. Evaluation of the predictive value of ICD-9-CM coded administrative data for venous thromboembolism in the United States. , 2010, Thrombosis research.
[16] Georg Heinze,et al. Risk Assessment of Recurrence in Patients With Unprovoked Deep Vein Thrombosis or Pulmonary Embolism: The Vienna Prediction Model , 2010, Circulation.
[17] Janet S. Lee,et al. Bad Blood: The risks of red cell storage , 2010, Nature Medicine.
[18] E. Unger,et al. Erythropoiesis-stimulating agents--time for a reevaluation. , 2010, The New England journal of medicine.
[19] A. Khorana,et al. Blood transfusions, thrombosis, and mortality in hospitalized patients with cancer. , 2008, Archives of internal medicine.
[20] Liam Smeeth,et al. Exposure to antipsychotics and risk of stroke: self controlled case series study , 2008, BMJ : British Medical Journal.
[21] D. Dorr,et al. Venous thromboembolism and mortality associated with recombinant erythropoietin and darbepoetin administration for the treatment of cancer-associated anemia. , 2008, JAMA.
[22] Patrick Musonda,et al. Tutorial in biostatistics: the self‐controlled case series method , 2006, Statistics in medicine.
[23] R. Hubbard,et al. Risk of deep vein thrombosis and pulmonary embolism after acute infection in a community setting , 2006, The Lancet.
[24] Pieter W Kamphuisen,et al. Effectiveness of managing suspected pulmonary embolism using an algorithm combining clinical probability, D-dimer testing, and computed tomography. , 2006, JAMA.
[25] S. Doucette,et al. Does this patient have deep vein thrombosis? , 1998, JAMA.
[26] D. Wagner,et al. New links between inflammation and thrombosis. , 2005, Arteriosclerosis, thrombosis, and vascular biology.
[27] A. Turpie,et al. Risk factors for venous thromboembolism in hospitalized patients with acute medical illness: analysis of the MEDENOX Study. , 2004, Archives of internal medicine.
[28] C. Esmon. The impact of the inflammatory response on coagulation. , 2004, Thrombosis research.
[29] N. Roubinian,et al. Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. , 2016, The Cochrane database of systematic reviews.
[30] J. Johannigman,et al. The risk assessment profile score identifies trauma patients at risk for deep vein thrombosis. , 2000, Surgery.
[31] M Maclure,et al. Should we use a case-crossover design? , 2000, Annual review of public health.
[32] M Gent,et al. Derivation of a Simple Clinical Model to Categorize Patients Probability of Pulmonary Embolism: Increasing the Models Utility with the SimpliRED D-dimer , 2000, Thrombosis and Haemostasis.
[33] R. Suzman,et al. An Overview of the Health and Retirement Study , 1995 .
[34] M. Maclure. The case-crossover design: a method for studying transient effects on the risk of acute events. , 1991, American journal of epidemiology.